Influence of New Eurotransplant Heart Allocation Policy on Outcome of Heart Transplant Candidates in Germany

Journal of Heart and Lung Transplantation

Volumn 27, Issue 10, 2008, Pages 1108-1114

  Komoda, Takeshi ^a   Hetzer, Roland ^a   Lehmkuhl, Hans B ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY;

ADULT; ALGORITHM; ARTICLE; CARDIAC GRAFT REJECTION; CARDIAC PATIENT; CRITICALLY ILL PATIENT; DRUG DOSE REDUCTION; FEMALE; GERMANY; HEALTH CARE POLICY; HEALTH CENTER; HEART ASSIST DEVICE; HEART FAILURE; HEART GRAFT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ALGORITHMS; CRITICAL ILLNESS; EUROPE; GERMANY; GRAFT SURVIVAL; HEART; HEART DISEASES; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; RESOURCE ALLOCATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; WAITING LISTS;

EID: 52949149276     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.07.011     Document Type: Article

References (22)

1. Stevenson L.W., Hamilton M.A., Tillisch I.H., et al. Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol 18 (1991) 919-925
2. Kao W., McGee D., Liao Y., et al. Does heart transplantation confer additional benefit over medical therapy to patients who have waited > 6 months for heart transplantation?. J Am Coll Cardiol 24 (1994) 1547-1551
3. Aaronson K.D., Schwartz J.S., Chen T.M., Wong K.L., Goin J.E., and Mancini D.M. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95 (1997) 2660-2667
4. Deng M.C., De Meester J.M., Smits J.M., Heinecke J., and Scheld H.H. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 321 (2000) 540-545
5. Jimenez J., Bennett Edwards L., et al. Should stable UNOS Status 2 patients be transplanted?. J Heart Lung Transplant 24 (2005) 178-183
6. Mudge G.H., Goldstein S., Addonizio L.J., et al. 24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol 22 (1993) 21-31
7. Renlund D.G., Taylor D.O., Kfoury A.G., and Shaddy R.S. New UNOS rules: historical background and implications for transplantation management. United Network for Organ Sharing. J Heart Lung Transplant 18 (1999) 1065-1070
8. van den Hout W.B., Smits J.M., Deng M.C., et al. The heart-allocation simulation model: a tool for comparison of transplantation allocation policies. Transplantation 76 (2003) 1492-1497
9. Richtlinien zur Organtransplantation gemäβ §16 Transplantationsgesetz. Duetsches Ärzteblatt 97 (2000) A396-A411
10. Komoda T., Drews T., Lehmkuhl H.B., and Hetzer R. Role of ventricular assist devices in the German heart allocation system. J Artif Organs 9 (2006) 29-33
11. Krakauer H., Lin M.J., and Bailey R.C. Projected survival benefit as criterion for listing and organ allocation in heart transplantation. J Heart Lung Transplant 24 (2005) 680-689
12. Mokadam N.A., Ewald G.A., Damiano Jr. R.J., and Moazami N. Deterioration and mortality among patients with United Network for Organ Sharing status 2 heart disease: caution must be exercised in diverting organs. J Thorac Cardiovasc Surg 131 (2006) 925-926
13. Lietz K., and Miller L.W. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005. J Am Coll Cardiol 50 (2007) 1282-1290
14. Groetzner J., Kaczmarek I., Meiser B., et al. The new German allocation system for donated thoracic organs causes longer ischemia and increased costs. Thorac Cardiovasc Surg 50 (2002) 376-379
15. Costard-Jackle A., Hirt S.W., Fischer B., et al. Influence of organ allocation on outcome of transplant candidates. Thorac Cardiovasc Surg 51 suppl 1 (2003) S64-S65
16. El-Banayosy A., Alsoglu L., Kizner L., Koertke H., Morshuls M., and Koerfer R. Impact of Eurotransplant high urgency (HU) listing criteria on a bridge to transplant population. Thorac Cardiovasc Surg 52 suppl 1 (2004) S17
17. Koch A., Tochtermann U., Remppis A., et al. The Eurotransplant High-Urgency Heart Transplantation Program: an option for patients in acute heart failure?. Thorac Cardiovasc Surg 54 (2006) 414-417
18. European Transplant Coordinators Organization. International figures on 1998 organ donation and transplantation activities. Organs Tissues 3 (1999) 142-145
19. Deng M.C., Smits J.M., De Meester J., Hummel M., Schoendube F., and Scheld H.H. Heart transplantation indicated only in the most severely ill patient: perspectives from the German heart transplant experience. Curr Opin Cardiol 16 (2001) 97-104
20. Osada K., and Imaizumi T. Special report from the heart transplant candidate registry committee in Japan. J Heart Lung Transplant 24 (2005) 810-814
21. Komoda T., Hetzer R., and Lehmkuhl H.B. Destiny of candidates for heart transplantation in the Eurotransplant heart allocation system. Eur J Cardiothorac Surg 34 (2008) 301-306
22. Kobashigawa J., Miller L., Renlund D., et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators. Transplantation 66 (1998) 507-515